The IFT20 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the IFT20 gene in the human HT29 colorectal adenocarcinoma cell line. This gene disruption pool provides a loss-of-function model for studying IFT20-dependent processes, avoiding clonal variation. Derived from Homo sapiens, the cells enable investigation of IFT20 biology within an intestinal epithelial context.
HT29 cells, isolated from a colorectal adenocarcinoma, display epithelial morphology and adherent growth. They serve as a model of human intestinal epithelium, capable of forming polarized monolayers and secreting mucins. Importantly, HT29 cells can generate primary cilia, which act as signaling platforms for Hedgehog and Wnt pathways. This combination of epithelial features and ciliary competence makes HT29 an appropriate host for dissecting IFT20-mediated intraflagellar transport in a cancerous intestinal environment.
IFT20 is an integral component of intraflagellar transport complex B, directing anterograde ciliary traffic. It physically associates with IFT88, IFT52, and the BBSome, and collaborates with GMAP210 to orchestrate Golgi-to-cilium and apical vesicle trafficking. IFT20 transports ciliary membrane proteins, including the Hedgehog receptors Smoothened and Patched, as well as PDGFR??. Transcriptional regulation by RFX factors and cellular stress positions IFT20 as a nexus for ciliogenesis control. Consequently, its disruption impairs ciliary protein delivery, attenuates Hedgehog signaling, and mislocalizes Wnt pathway components.
Knockout of IFT20 in HT29 cells is anticipated to ablate primary cilium assembly and downstream signaling, given the cell line’s ciliogenic potential. This polyclonal model enables examination of how defective intraflagellar transport affects colorectal cancer cell phenotypes, such as migration and invasion. Moreover, because HT29 cells are mucin-producing and polarized, the knockout system can be used to study IFT20??s role in apical trafficking and epithelial barrier integrity. The resultant ciliary dysfunction provides a direct link between IFT20 loss and dysregulated Hedgehog/Wnt outputs frequently observed in colorectal malignancies.
This IFT20 knockout population supports a broad array of functional assays. Immunofluorescence for acetylated tubulin and ARL13B permits visualization and quantification of cilia length and morphology. Western blotting and RT-qPCR allow assessment of IFT20 depletion and Hedgehog target gene induction. Co-immunoprecipitation experiments can probe interactions with partners like IFT88 and GMAP210. Flow cytometry and phospho-signaling analyses facilitate pathway activity profiling. Migration and invasion assays offer insights into metastatic behavior. Researchers can thus apply this model to investigate ciliopathy mechanisms, interrogate Wnt and Hedgehog signaling in colorectal cancer, and screen for cilia-targeted therapeutics. For further information, please contact Ascent Research.
